Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasms 1 Malignant Disease 1

Interventions

Carboplatin 49 Etoposide 46 Cisplatin 42 Topotecan 39 Irinotecan 21 Paclitaxel 20 Nivolumab 15 pembrolizumab 13 Gemcitabine 13 atezolizumab 11 Ipilimumab 11 durvalumab 9 Radiotherapy 9 Doxorubicin 7 Bevacizumab 7 rovalpituzumab tesirine 6 etoposide phosphate 6 amrubicin 6 Psychiatric Rehabilitation 6 PM 01183 6 Docetaxel 6 Counseling 6 trilaciclib 5 Temozolomide 5 Sunitinib 5 Platinum 5 Imatinib Mesylate 5 Cyclophosphamide 5 Bortezomib 5 130-nm albumin-bound paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Small Cell Lung Carcinoma × amuvatinib × Clear all

NCT01357395 2024-08-02

ESCAPE

Astex Pharmaceuticals, Inc.

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡